Cargando…
Improvement in β-Cell Secretory Capacity After Human Islet Transplantation According to the CIT07 Protocol
The Clinical Islet Transplantation 07 (CIT07) protocol uses antithymocyte globulin and etanercept induction, islet culture, heparinization, and intensive insulin therapy with the same low-dose tacrolimus and sirolimus maintenance immunosuppression as in the Edmonton protocol. To determine whether CI...
Autores principales: | Rickels, Michael R., Liu, Chengyang, Shlansky-Goldberg, Richard D., Soleimanpour, Scott A., Vivek, Kumar, Kamoun, Malek, Min, Zaw, Markmann, Eileen, Palangian, Maral, Dalton-Bakes, Cornelia, Fuller, Carissa, Chiou, Allen J., Barker, Clyde F., Luning Prak, Eline T., Naji, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717864/ https://www.ncbi.nlm.nih.gov/pubmed/23630300 http://dx.doi.org/10.2337/db12-1802 |
Ejemplares similares
-
Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 Diabetes
por: Rickels, Michael R., et al.
Publicado: (2015) -
RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes
por: Panigrahi, Anil K., et al.
Publicado: (2008) -
Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes
por: Gudipaty, Lalitha, et al.
Publicado: (2014) -
CIT
por: Odom, Sean
Publicado: (2004) -
Loss-of-Function Mutations in ABCA1 and Enhanced β-Cell Secretory Capacity in Young Adults
por: Rickels, Michael R., et al.
Publicado: (2015)